You are here
STEALTH BIOLOGICS LLC
UEI: G7YSH33A2617
# of Employees: 2
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Engineering a potent immune-evading uricase
Amount: $1,000,000.00Abstract The accumulation of uric acid in the urinary tract, blood stream, or tissues causes a pathological condition known as hyperuricemia, which leads to a variety of acute and chronic diseases inc ...
SBIRPhase II2021Department of Health and Human Services National Institutes of Health -
Engineering a Potent Immune-evading Uricase
Amount: $299,870.00Abstract The accumulation of uric acid in the urinary tract, blood stream, or tissues causes a pathological condition known as hyperuricemia, which leads to a variety of acute and chronic diseases inc ...
SBIRPhase I2020Department of Health and Human Services National Institutes of Health -
Deimmunized Griffithsin Microbicide
Amount: $299,275.00The mannose binding lectin Griffithsin (GRFT) represents an exciting new approach to preventing infection by HIV-1 and herpes simplex virus 2 (HSV-2). GRFT binds the dense glycan shield on the HIV-1 a ...
SBIRPhase I2020Department of Health and Human Services National Institutes of Health -
Improving HSV-2 vaccine efficacy by focusing antibody epitope coverage.
Amount: $284,815.00A vaccine for prevention of genital herpes is a high public health priorityWe are evaluating a trivalent subunit antigen vaccine that contains herpes simplex virus typeHSVglycoproteins CDand EgCgDgEGl ...
STTRPhase I2019Department of Health and Human Services National Institutes of Health -
Design and Development of Immunotolerant S. aureus Biotherapies
Amount: $185,930.00DESCRIPTION provided by applicant Antibiotic resistance complicates the majority of Staphylococcus aureus S aureus infections as a full two thirds of hospital associated S aureus infections an ...
STTRPhase I2015Department of Health and Human Services National Institutes of Health